Found 534 hits.
| 234 | Longhurst, H. J.+, Aberer, W., Bouillet, L., Caballero, T., Maurer, M. Fabien, V., Zanichelli, A.: The icatibant outcome survey: treatment of laryngeal angioedema attacks. Eur. J. Emerg. Med. 2016: 23; 224-227. IF: 2.02 |
| 219 | Weller, K.+, Maurer, M. Grattan, C., Nakonechna, A., Abuzakouk, M., Bérard, F., Sussman, G., Giménez-Arnau, A. M., Ortiz de Frutos, J., Knulst, A., Canonica, G. W., Hollis, K., McBride, D., and Balp, M. M.: ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria. Clin. Transl. Allergy 2015: 5; 29. IF N/A |
| 131 | Magerl, M.*, Pisarevskaja, D.*, Staubach, P., Martus, P., Church, M. K.+, and Maurer, M.:Â Critical temperature threshold measurement for cold urticaria: a randomised controlled trial of H1-antihistamine up-dosing. Brit. J. Dermatol. 2012: 166; 1095-1099. IF: 3.75 |
o.131
| 423. | Song, X., Chen, Y.-D., Yu, M., Liu, B., Zhao, Z. T.+, and Maurer, M.+: Omalizumab in children and adolescents with chronic urticaria: a 16 week real-world study. Allergy 2021: 76; 1271-1273. IF: 14.71 |
o.423
| 122 | Kalogeromitros, D.+, Psaltopoulou, T., Koti, I., Chliva, C., Stefanadi, E., Makris, M., and Maurer, M.: Can internet surveys help us understanding allergic disorders? – Results from a large survey in urticaria in Greece. J. Eur. Acad. Dermatol. Venereol. 2011: 25; 532-537. IF: 2.98 |
| 31. | Weller, K. and Maurer, M.: Chronic urticaria. In: Naldi, Williams, H., Bigby, M., Herxheimer, A., Naldi, L., Rzany, B., Dellavalle, R., Ran, Y., and Furue, M., editors: Evidence-based dermatology. 3rd ed., Oxford: Wiley, 2014 |
| 284 | Stull, D.+, McBride, D., Tian, H., Giménez-Arnau, A., Maurer, M. Marsland, A., Balp, M. M., Khalil, S., and Grattan, C.: Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria. Brit. J. Dermatol. 2017: 177; 1093-1101. IF: 6.13 |
| 85 | Magerl, M., Borzova, E., Giménez-Arnau, A., Grattan, C. E. H., Lawlor, F., Mathelier-Fusade, P., Metz, M., Młynek, A., and Maurer, M.+: The definition and diagnostic testing of physical and cholinergic urticarias – EAACI/GA²LEN/EDF/UNEV consensus panel recommendations. Allergy 2009: 64; 1715-1721. IF: 6.38 |
o.085
Zur Person Prof. Dr. med. Marcus Maurer Geschäftsführender Direktor des Institute of Allergology der Charité – Universitätsmedizin Berlin.Co-Direktor für den Fraunhofer Standort für Immunologie und
| 155 | MÅ‚ynek, A., Vieira dos Santos, R., Ardelean, E., Weller, K., Magerl, M., Church, M. K., and Maurer, M.+: A novel, simple, validated and reproducible instrument for assessing provocation threshold levels in patients with symptomatic dermographism. Clin. Exp. Dermatol. 2013: 38; 360-366. IF: 1.23 |
o.155